OpenAI agrees to acquire Orchestra Bio for biopharma AI operations
OpenAI is acquiring Orchestra Bio to bring AI-powered operations to life sciences research and development. The companies’ stated aim is to help biopharmaceutical teams accelerate drug development and advance new treatments. The report provides no transaction…
